Pre-morbid use of proton pump inhibitors has no effect on the risk of death or hospitalization in COVID-19 patients: a matched cohort study
View ORCID ProfileIvan Kodvanj, View ORCID ProfileJan Homolak, Vladimir Trkulja
doi: https://doi.org/10.1101/2022.04.30.22274526
Ivan Kodvanj
1Department of Gastroenterology and Hepatology, University Hospital Centre Zagreb, Zagreb, Croatia
Jan Homolak
2Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia
Vladimir Trkulja
2Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia
Data Availability
Data can be obtained upon a reasonable request directly from the Croatian institute for public health.
Posted May 01, 2022.
Pre-morbid use of proton pump inhibitors has no effect on the risk of death or hospitalization in COVID-19 patients: a matched cohort study
Ivan Kodvanj, Jan Homolak, Vladimir Trkulja
medRxiv 2022.04.30.22274526; doi: https://doi.org/10.1101/2022.04.30.22274526
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)